Related Experiment Video

Updated: May 17, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

4-1BB protects dendritic cells from prostate cancer-induced apoptosis

Kuang Youlin1, Zhang Jianwei, Gou Xin

  • 1Department of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, 400016, China.

Pathology Oncology Research : POR
|October 17, 2012
PubMed

Insights

Activating 4-1BB on dendritic cells (DCs) enhances their resistance to prostate cancer (PCa)-induced apoptosis. This protection involves increased Bcl-2/Bcl-xL expression and cytokine production, crucial for anti-tumor immunity.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Prostate cancer (PCa) cells induce apoptosis in dendritic cells (DCs), impairing anti-tumor immune responses.
  • Dendritic cells are critical for initiating specific anti-tumor immunity.
  • The role of 4-1BB in protecting DCs from PCa-induced apoptosis requires investigation.

Purpose of the Study:

  • To investigate the protective function of 4-1BB signaling on dendritic cells against prostate cancer-induced apoptosis.
  • To determine if activating 4-1BB can enhance DC survival and function in the context of prostate cancer.

Main Methods:

  • Co-incubation of RM-1 prostate cancer cells with dendritic cells (DCs) for 48 hours.
  • Assessment of DC apoptosis using Annexin V assay.
  • Measurement of TNF-α and IL-12 production via ELISA.
  • Analysis of Bcl-2 and Bcl-xL protein expression in DCs using Western blot.

Main Results:

  • Co-incubation of RM-1 cells with DCs led to increased DC apoptosis.
  • Triggering 4-1BB on DCs significantly increased their resistance to PCa-induced apoptosis.
  • This enhanced resistance was associated with upregulated Bcl-2 and Bcl-xL expression.
  • Increased secretion of TNF-α and IL-12 was observed in 4-1BB-stimulated DCs.

Conclusions:

  • Activating 4-1BB on dendritic cells enhances their resistance to prostate cancer-induced apoptosis.
  • Upregulation of Bcl-2, Bcl-xL, TNF-α, and IL-12 contributes to 4-1BB-mediated DC protection.
  • Targeting 4-1BB on DCs represents a potential strategy to improve anti-tumor immunity in prostate cancer.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...